{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:38:21Z","timestamp":1791952701670,"version":"4.3.4"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003581","name":"American Hungarian Foundation","doi-asserted-by":"publisher","award":["OTKA-K 132828"],"award-info":[{"award-number":["OTKA-K 132828"]}],"id":[{"id":"10.13039\/100003581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","award":["11003"],"award-info":[{"award-number":["11003"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001649","name":"European Geosciences Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001649","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001738","name":"Ministry of Innovation, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020916","name":"Hungarian Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018818","name":"National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["TKP2021-EGA-18"],"award-info":[{"award-number":["TKP2021-EGA-18"]}],"id":[{"id":"10.13039\/501100018818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["EFOP-3.6.2-16-2017-00006"],"award-info":[{"award-number":["EFOP-3.6.2-16-2017-00006"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","award":["TKP2020-NKA-04"],"award-info":[{"award-number":["TKP2020-NKA-04"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.redox.2024.103316","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T07:05:08Z","timestamp":1723791908000},"page":"103316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Heme: A link between hemorrhage and retinopathy of prematurity progression"],"prefix":"10.1016","volume":"76","author":[{"given":"Tam\u00e1s","family":"G\u00e1ll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1vid","family":"Peth\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Erd\u00e9lyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vir\u00e1g","family":"Egri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1zon Gy\u00f6rgy","family":"Balla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annam\u00e1ria","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annam\u00e1ria","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szil\u00e1rd","family":"P\u00f3liska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Gram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"G\u00e1briel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zsef","family":"Balla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Balla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2024.103316_bib1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cphy.c190021","article-title":"Retinal physiology and circulation: effect of diabetes","volume":"10","author":"Wright","year":"2020","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.redox.2024.103316_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12040903","article-title":"Metabolism and vascular retinopathies: current perspectives and future directions","volume":"12","author":"Singh","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.redox.2024.103316_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40348-023-00163-5","article-title":"Retinopathy of prematurity: from oxygen management to molecular manipulation","volume":"10","author":"Woods","year":"2023","journal-title":"Mol Cell Pediatr"},{"key":"10.1016\/j.redox.2024.103316_bib4","article-title":"Clinical characteristics, risk factors and short-term prognosis of retinopathy of prematurity complicated with retinal hemorrhage","author":"Li","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib5","first-page":"262","article-title":"Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects","volume":"40","author":"Terry","year":"1942","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.redox.2024.103316_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","article-title":"Retinopathy of prematurity","volume":"10","author":"Chen","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.redox.2024.103316_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2023.04.004","article-title":"Causes of childhood blindness in the United States using the IRIS\u00ae Registry (intelligent research in Sight)","author":"Lim","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.redox.2024.103316_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/ceo.14237","article-title":"Spectrum of ocular disease in children aged between 0 and 3 years at an Australian paediatric tertiary hospital","author":"Lo-Cao","year":"2023","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000444901","article-title":"Retinopathy of prematurity: therapeutic strategies based on pathophysiology","volume":"109","author":"Cayabyab","year":"2016","journal-title":"Neonatology"},{"key":"10.1016\/j.redox.2024.103316_bib10","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.101113998","article-title":"Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity","volume":"98","author":"Hellstrom","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2024.103316_bib11","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2024.103316_bib12","first-page":"1201","article-title":"The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis","volume":"36","author":"Chan-Ling","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2024.103316_bib13","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.redox.2024.103316_bib14","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2024.103316_bib15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023290118","article-title":"A specific RIP3(+) subpopulation of microglia promotes retinopathy through a hypoxia-triggered necroptotic mechanism","volume":"118","author":"He","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2024.103316_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109347","article-title":"Ferrostatin-1 attenuates pathological angiogenesis in oxygen-induced retinopathy via inhibition of ferroptosis","volume":"226","author":"Liu","year":"2023","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.redox.2024.103316_bib17","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41433-022-02335-5","article-title":"Perspectives of diabetic retinopathy-challenges and opportunities","volume":"37","author":"Sivaprasad","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.redox.2024.103316_bib18","article-title":"Effectiveness of panretinal photocoagulation plus intravitreal anti-VEGF treatment against prp alone for diabetic retinopathy: a systematic review with meta-analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.redox.2024.103316_bib19","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1073\/pnas.90.20.9285","article-title":"Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage","volume":"90","author":"Balla","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2024.103316_bib20","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1074\/jbc.272.11.7114","article-title":"The globin-based free radical of ferryl hemoglobin is detected in normal human blood","volume":"272","author":"Svistunenko","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2024.103316_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/10715769609149916","article-title":"Redox cycling of human methaemoglobin by H2O2 yields persistent ferryl iron and protein based radicals","volume":"25","author":"Patel","year":"1996","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2024.103316_bib22","first-page":"992","article-title":"The red blood cell and vascular function in health and disease","volume":"6","author":"Crawford","year":"2004","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2024.103316_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.clp.2019.05.015","article-title":"Current recommendations and practice of oxygen therapy in preterm infants","volume":"46","author":"Tarnow-Mordi","year":"2019","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.redox.2024.103316_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jpeds.2018.10.033","article-title":"rhIGF-1\/rhIGFBP-3 in preterm infants: a phase 2 randomized controlled trial","volume":"206","author":"Ley","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.redox.2024.103316_bib25","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2024.103316_bib26","first-page":"228","article-title":"Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options","volume":"6","author":"Mutlu","year":"2013","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-023-02559-z","article-title":"Comparison of long-term treatment outcomes of laser and anti-VEGF therapy in retinopathy of prematurity: a multicentre study from J-CREST group","author":"Murakami","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.redox.2024.103316_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00417-010-1315-z","article-title":"A review of clinical trials of anti-VEGF agents for diabetic retinopathy","volume":"248","author":"Nicholson","year":"2010","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.redox.2024.103316_bib30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1050-1738(98)00020-6","article-title":"Hypoxic regulation of VEGF mRNA stability by RNA-binding proteins","volume":"8","author":"Levy","year":"1998","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.redox.2024.103316_bib31","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2337\/diabetes.47.9.1480","article-title":"Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells","volume":"47","author":"Takagi","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2024.103316_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metabol."},{"key":"10.1016\/j.redox.2024.103316_bib33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jcp.24133","article-title":"Suppression of GLUT1; a new strategy to prevent diabetic complications","volume":"228","author":"Lu","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.redox.2024.103316_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.107997","article-title":"A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia\/reperfusion injury","volume":"193","author":"Sato","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.redox.2024.103316_bib35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/15230860260220076","article-title":"Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1","volume":"4","author":"Jozkowicz","year":"2002","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2024.103316_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yjmcc.2008.04.011","article-title":"Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1","volume":"45","author":"Lin","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.redox.2024.103316_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-016-0219-6","article-title":"Blocking heme oxygenase-1 by zinc protoporphyrin reduces tumor hypoxia-mediated VEGF release and inhibits tumor angiogenesis as a potential therapeutic agent against colorectal cancer","volume":"23","author":"Cheng","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.redox.2024.103316_bib38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/152308602753666280","article-title":"Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells","volume":"4","author":"Dulak","year":"2002","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2024.103316_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2004.04.018","article-title":"Innate immunity in the retina: toll-like receptor (TLR) signaling in human retinal pigment epithelial cells","volume":"153","author":"Kumar","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.redox.2024.103316_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105960","article-title":"Role of toll-like receptor 4 in diabetic retinopathy","volume":"175","author":"Bayan","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.redox.2024.103316_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/13813455.2020.1841795","article-title":"Deletion of toll-like receptor 4 ameliorates diabetic retinopathy in mice","volume":"129","author":"Fu","year":"2023","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.redox.2024.103316_bib42","doi-asserted-by":"crossref","first-page":"20221","DOI":"10.1074\/jbc.M610737200","article-title":"Characterization of heme as activator of Toll-like receptor 4","volume":"282","author":"Figueiredo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2024.103316_bib43","doi-asserted-by":"crossref","first-page":"38205","DOI":"10.1074\/jbc.M203781200","article-title":"Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells","volume":"277","author":"Fukuda","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2024.103316_bib44","first-page":"363","article-title":"Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1","volume":"12","author":"Jiang","year":"2001","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.redox.2024.103316_bib45","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression","volume":"21","author":"Laughner","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.redox.2024.103316_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.redox.2024.103316_bib47","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","article-title":"Mechanism of activation of protein kinase B by insulin and IGF-1","volume":"15","author":"Alessi","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.redox.2024.103316_bib48","first-page":"1957","article-title":"The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells","volume":"8","author":"Semba","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2024.103316_bib49","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.febslet.2008.08.005","article-title":"Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro","volume":"582","author":"Stahl","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.redox.2024.103316_bib50","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.3892\/mmr.2017.6418","article-title":"Effects of GSK2606414 on cell proliferation and endoplasmic reticulum stress-associated gene expression in retinal pigment epithelial cells","volume":"15","author":"Jiang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.redox.2024.103316_bib51","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1167\/iovs.11-8045","article-title":"Diabetic retinopathy and damage to mitochondrial structure and transport machinery","volume":"52","author":"Zhong","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.redox.2024.103316_bib52","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.bbadis.2015.08.001","article-title":"Oxidative stress, mitochondrial damage and diabetic retinopathy","volume":"1852","author":"Kowluru","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2024.103316_bib53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.thj.6200190","article-title":"Hemoglobin induces the expression and secretion of vascular endothelial growth factor from human malignant cells","volume":"3","author":"Siddiqui","year":"2002","journal-title":"Hematol J"},{"key":"10.1016\/j.redox.2024.103316_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0002-9394(03)00190-9","article-title":"Vitreous hemorrhage in patients with high-risk retinopathy of prematurity","volume":"136","author":"Hutcheson","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib55","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.biochi.2018.06.019","article-title":"The role of the retinal pigment epithelium and M\u00fcller cells secretome in neovascular retinal pathologies","volume":"155","author":"Ara\u00fajo","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.redox.2024.103316_bib56","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.1073\/pnas.1504387112","article-title":"Nuclear receptor ROR\u03b1 regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation","volume":"112","author":"Sun","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2024.103316_bib57","first-page":"6742","article-title":"Angiopoietin-like protein 4 (ANGPTL4) induces retinal pigment epithelial barrier breakdown by activating signal transducer and activator of transcription 3 (STAT3): evidence from ARPE-19 cells under hypoxic condition and diabetic rats","volume":"25","author":"Yang","year":"2019","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.redox.2024.103316_bib58","article-title":"Thrombospondin-1 deficiency exacerbates the pathogenesis of diabetic retinopathy","volume":"12","author":"Sorenson","year":"2013","journal-title":"J. Diabetes Metabol."},{"key":"10.1016\/j.redox.2024.103316_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105755","article-title":"Mfsd2a overexpression alleviates vascular dysfunction in diabetic retinopathy","volume":"171","author":"Zhang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.redox.2024.103316_bib60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajo.2006.07.032","article-title":"Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy","volume":"143","author":"Petrovic","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib61","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7150\/jca.66773","article-title":"PFKFB4 promotes angiogenesis via IL-6\/STAT5A\/P-STAT5 signaling in breast cancer","volume":"13","author":"Li","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.redox.2024.103316_bib62","article-title":"KLF4 promotes angiogenesis by activating VEGF signaling in human retinal microvascular endothelial cells","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2024.103316_bib63","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2174\/13894501113149990015","article-title":"Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases","volume":"14","author":"Vadlapatla","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.redox.2024.103316_bib64","first-page":"5071","article-title":"Effects of HIF-1\u03b1 on diabetic retinopathy angiogenesis and VEGF expression","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.redox.2024.103316_bib65","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00004647-200206000-00007","article-title":"Hypoxia-inducible factor-1alpha accumulation in the brain after experimental intracerebral hemorrhage","volume":"22","author":"Jiang","year":"2002","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.redox.2024.103316_bib66","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1038\/s41598-022-08492-7","article-title":"Evaluation of vascular endothelial growth factor (VEGF) level in the tears and serum of age-related macular degeneration patients","volume":"12","author":"Shahidatul-Adha","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2024.103316_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbapap.2015.10.002","article-title":"Structural and biochemical characterization of two heme binding sites on \u03b11-microglobulin using site directed mutagenesis and molecular simulation","volume":"1864","author":"Rutardottir","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2024.103316_bib68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro","year":"2014","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib69","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ajo.2009.07.007","article-title":"Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy","volume":"148","author":"Wang","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib70","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ophtha.2022.06.042","article-title":"A network meta-analysis of retreatment rates following bevacizumab, ranibizumab, aflibercept, and laser for retinopathy of prematurity","volume":"129","author":"Chang","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.redox.2024.103316_bib71","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/14712598.2022.2100694","article-title":"Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?","volume":"22","author":"Uludag","year":"2022","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.redox.2024.103316_bib72","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11892-022-01491-y","article-title":"Systemic and ocular adverse events with intravitreal anti-VEGF therapy used in the treatment of diabetic retinopathy: a review","volume":"22","author":"Zehden","year":"2022","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.redox.2024.103316_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007867","article-title":"Selective inhibition of retinal angiogenesis by targeting PI3 kinase","volume":"4","author":"Alvarez","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2024.103316_bib74","first-page":"1284","article-title":"Inhibition of LY294002 in retinal neovascularization via down-regulation the PI3K\/AKT-VEGF pathway in vivo and in vitro","volume":"11","author":"Di","year":"2018","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib75","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1002\/j.1460-2075.1996.tb00911.x","article-title":"Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002","volume":"15","author":"Brunn","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.redox.2024.103316_bib76","first-page":"10167","article-title":"Anti-angiogenic effect of rapamycin in mouse oxygen-induced retinopathy is mediated through suppression of HIF-1alpha\/VEGF pathway","volume":"10","author":"Sun","year":"2017","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.redox.2024.103316_bib77","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1159\/000453207","article-title":"Blocking mammalian target of rapamycin (mTOR) attenuates HIF-1\u03b1 pathways engaged-vascular endothelial growth factor (VEGF) in diabetic retinopathy","volume":"40","author":"Wei","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.redox.2024.103316_bib78","first-page":"1704","article-title":"Association between endoplasmic reticulum stress and risk factors of diabetic retinopathy","volume":"11","author":"Kong","year":"2018","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib79","doi-asserted-by":"crossref","first-page":"77219","DOI":"10.18632\/oncotarget.20431","article-title":"Salubrinal attenuated retinal neovascularization by inhibiting CHOP-HIF1\u03b1-VEGF pathways","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.redox.2024.103316_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89713-3","article-title":"Heme cytotoxicity is the consequence of endoplasmic reticulum stress in atherosclerotic plaque progression","volume":"11","author":"Peth\u0151","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2024.103316_bib81","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/768026","article-title":"Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration","volume":"2014","author":"Blasiak","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.redox.2024.103316_bib82","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/157339911797415620","article-title":"Hypoxia and oxidative stress in the causation of diabetic retinopathy","volume":"7","author":"Arden","year":"2011","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.redox.2024.103316_bib83","doi-asserted-by":"crossref","first-page":"18148","DOI":"10.1016\/S0021-9258(19)37165-0","article-title":"Ferritin: a cytoprotective antioxidant strategem of endothelium","volume":"267","author":"Balla","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2024.103316_bib84","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/cam4.112","article-title":"BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I","volume":"2","author":"Ellinghaus","year":"2013","journal-title":"Cancer Med."},{"key":"10.1016\/j.redox.2024.103316_bib85","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14319","article-title":"Hypoxia-induced metabolic stress in retinal pigment epithelial cells is sufficient to induce photoreceptor degeneration","volume":"5","author":"Kurihara","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.redox.2024.103316_bib86","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mam.2009.12.005","article-title":"Mitochondria as targets in angiogenesis inhibition","volume":"31","author":"Park","year":"2010","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.redox.2024.103316_bib87","doi-asserted-by":"crossref","first-page":"77020","DOI":"10.18632\/oncotarget.20331","article-title":"VEGF stimulated the angiogenesis by promoting the mitochondrial functions","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.redox.2024.103316_bib88","doi-asserted-by":"crossref","first-page":"C695","DOI":"10.1152\/ajpcell.00322.2010","article-title":"Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species","volume":"301","author":"Wang","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.redox.2024.103316_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153675","article-title":"Heme oxygenase, and endoplasmic reticulum stress-A new insight into the pathophysiology of vascular diseases","volume":"20","author":"G\u00e1ll","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2024.103316_bib90","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1006\/bbrc.1993.1671","article-title":"Synthesis and secretion of vascular permeability factor\/vascular endothelial growth factor by human retinal pigment epithelial cells","volume":"193","author":"Adamis","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2024.103316_bib91","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0002-9440(10)64063-1","article-title":"Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium","volume":"158","author":"Schwesinger","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.redox.2024.103316_bib92","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9440(10)64525-7","article-title":"Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization","volume":"157","author":"Spilsbury","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.redox.2024.103316_bib93","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-017-0943-1","article-title":"Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies","volume":"14","author":"Rivera","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.redox.2024.103316_bib94","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib95","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International classification of retinopathy of prematurity, third edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.redox.2024.103316_bib96","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archophthalmol.2010.72","article-title":"Final visual acuity results in the early treatment for retinopathy of prematurity study","volume":"128","author":"Good","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.redox.2024.103316_bib97","doi-asserted-by":"crossref","first-page":"29582","DOI":"10.1074\/jbc.M109.045344","article-title":"Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells","volume":"284","author":"Silva","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2024.103316_bib98","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0076-6879(90)86118-F","article-title":"Oxidative reactions of hemoglobin","volume":"186","author":"Winterbourn","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.redox.2024.103316_bib99","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/ATVBAHA.110.206433","article-title":"Red cells, hemoglobin, heme, iron, and atherogenesis","volume":"30","author":"Nagy","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231724002945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231724002945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T09:29:43Z","timestamp":1727256583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231724002945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":99,"alternative-id":["S2213231724002945"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2024.103316","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heme: A link between hemorrhage and retinopathy of prematurity progression","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2024.103316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103316"}}